Page last updated: 2024-11-06

thyroxine and Encephalitis, Limbic

thyroxine has been researched along with Encephalitis, Limbic in 2 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Research Excerpts

ExcerptRelevanceReference
" We report a case highlighting the occurrence of serious induced immune-related adverse events, which were attributed to pembrolizumab in a patient with metastatic melanoma who obtained a complete response (CR) after receiving pembrolizumab for a total of 6."1.46Risk of cumulative toxicity after complete melanoma response with pembrolizumab. ( Brown, MP; Faithfull, S; Hsieh, AH, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, CH1
Lin, JJ1
Lin, KJ1
Chang, BL1
Hsieh, HY1
Chen, WH1
Lin, KL1
Fung, HC1
Wu, T1
Hsieh, AH1
Faithfull, S1
Brown, MP1

Other Studies

2 other studies available for thyroxine and Encephalitis, Limbic

ArticleYear
Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma.
    Journal of the neurological sciences, 2014, Jun-15, Volume: 341, Issue:1-2

    Topics: Aged; Antigens, Nuclear; Autoantibodies; Brain; Case-Control Studies; Cell Line, Transformed; Female

2014
Risk of cumulative toxicity after complete melanoma response with pembrolizumab.
    BMJ case reports, 2017, Feb-01, Volume: 2017

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Drug Eruptions; Groin; Hormone Repla

2017